In this video Doctor Matthew Burge leads a discussion on clinical challenges with resectable mCRC and clinical challenges with BRAF V600E mutant mCRC.
Dr Matthew Burge is a Medical Oncologist at Icon Cancer Centre and Staff Specialist at the Royal Brisbane and Women’s Hospital, Prince Charles Hospital and Rockhampton Mater Hospital.
This video is part of a series in which leading experts describe their approaches to common clinical challenges in mCRC through case-based discussion.
Other videos in the series include:
- Metastatic rectal cancer at presentation – Prof Peter Gibbs
- What is the role of FOLFOXIRI, and where does bevacizumab fit in for potentially operable mCRC? – Prof Chris Karapetis
- Molecular testing in treatment naïve mCRC, and dMMR/MSI-H mCRC – A/Prof Jeanne Tie
These videos were created independently by the limbic. All case studies were developed by the presenters and views are those of the presenters alone.
Thank you to MSD Australia for providing a non-restrictive educational grant that made this project possible.